In future studies, it will be interesting to assess the effect of HDAC6 inhibition in the modulation of other degradation pathways, such as macro-autophagy, in models of PD developing alpha-synuclein aggregates, such as the alpha-synuclein BAC transgenic rats27. Here, HDAC6 is linked to Parkinson disease.